KLK3 and neoplasm: Intrinsic markers of tumour hypoxia (i.e. hypoxia-inducible factor 1-alpha) have also been investigated and increased expression identified patients with shorter time to biochemical failure independent of clinical tumour stage, biopsy Gleason score, serum prostate-specific antigen concentration, and radiotherapy dose [29].